Clinical Trial Update: Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating carboplatin, gemcitabine, and thalidomide in patients undergoing surgery for stage II-III non-small cell lung cancer; the study is t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Thalidomide (thalidomide)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2009-12-03